Edgemoor Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Edgemoor Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-725	Closed	-$402K	–	168
2023 Q4	$402K	Buy	725 +50	+7%	+$23.5K	0.04%	116
2023 Q3	$295K	Hold	675	–	–	0.03%	129
2023 Q2	$339K	Hold	675	–	–	0.04%	122
2023 Q1	$338K	Sell	675 -20	-3%	-$9.57K	0.04%	122
2022 Q4	$284K	Buy	695 +20	+3%	+$7.76K	0.04%	139
2022 Q3	$220K	Hold	675	–	–	0.03%	134
2022 Q2	$237K	Hold	675	–	–	0.03%	140
2022 Q1	$369K	Sell	675 -175	-21%	-$92.1K	0.04%	124
2021 Q4	$560K	Hold	850	–	–	0.06%	99
2021 Q3	$529K	Hold	850	–	–	0.06%	95
2021 Q2	$537K	Hold	850	–	–	0.05%	93
2021 Q1	$416K	Hold	850	–	–	0.04%	96
2020 Q4	$425K	Hold	850	–	–	0.05%	94
2020 Q3	$334K	Hold	850	–	–	0.04%	99
2020 Q2	$281K	Hold	850	–	–	0.04%	105
2020 Q1	$206K	Hold	850	–	–	0.03%	112
2019 Q4	$222K	Hold	850	–	–	0.03%	127
2019 Q3	$231K	Hold	850	–	–	0.03%	124
2019 Q2	$234K	Buy	+850	New	+$209K	0.03%	127

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Edgemoor Investment Advisors's IDXX Position: Q1 2024 in Review

Edgemoor Investment Advisors sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 725 shares — an estimated $402K sold.

Edgemoor Investment Advisors first reported a position in IDXX in Q2 2019 and held it in 19 quarters. The position peaked at $560K in Q4 2021. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Edgemoor Investment Advisors reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Edgemoor Investment Advisors sold 725 Idexx Laboratories shares in Q1 2024, an estimated $402K.
Edgemoor Investment Advisors first reported a position in Idexx Laboratories in Q2 2019 and held it in 19 quarters.
Edgemoor Investment Advisors's Idexx Laboratories position peaked at $560K in Q4 2021.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Edgemoor Investment Advisors's 13F filing for Q1 2024, filed 9 May 2024.